Zinc for Eczema: Low-Zinc Studies, Trial Results and Dose Labels

Zinc for eczema is not a demonstrated treatment for everyone with atopic dermatitis. An eight-week placebo-controlled pediatric trial found no significant benefit; a later study restricted to children with low hair zinc reported improvement. That distinction concerns the people studied, not a guarantee that a zinc supplement will clear a rash.

1991 placebo-controlled trial · 2014 study: full report · Sources checked September 24, 2026.

What the negative trial actually tested

The 1991 double-blind trial included 50 children aged 1–16 and tested oral zinc sulphate, 185.4 mg per day, against placebo for eight weeks. The abstract reports no significant improvement in affected area, redness, itch, sleep disturbance or use of emollients and topical steroids. It does not describe selecting participants by low hair zinc.

The reported quantity is zinc sulphate, not an instruction to take that amount of elemental zinc. The abstract does not give a conversion, so none is inferred here.

Original trial abstract · NIH: elemental zinc labeling · Sources checked September 24, 2026.

What changed in the low-hair-zinc study

The study in the 2014 journal issue measured 58 children with atopic dermatitis and 43 controls, aged 2–14. Its treatment comparison involved 41 children below its hair-zinc cutoff of 130 micrograms/g: 22 received supplementation and 19 did not. Both groups used antihistamines and moisturizers; a blinded dermatologist assessed them. The comparator was no zinc supplementation, not a matching placebo tablet.

The report specifies zinc oxide tablets providing 12 mg as zinc over an eight-week regimen. Mean EASI severity scores fell from 6.56 to 1.73 with zinc and from 6.32 to 3.29 without it. The between-group comparison at eight weeks was statistically significant. These are study measurements, not dosing advice.

Our comparison: this was an addition to background care in a selected pediatric group. Calling it zinc alone for all eczema would change both the treatment and the population.

2014 original report: methods and results · Sources checked September 24, 2026.

A hair measurement is not the same as a blood measurement

A separate 1987 observational study compared 43 children with allergic disease—including 21 with eczema—with 19 healthy children. It found lower mean hair zinc in the allergic group but no difference in serum zinc. The study did not test whether a supplement treated eczema.

That is a useful limit on interpretation: the sample material matters. An association in hair cannot silently be relabeled as a serum finding or a treatment result. It also does not make every child with eczema zinc-deficient.

Original observational study · Sources checked September 24, 2026.

Why a bottle label and a trial dose can look incompatible

NIH explains that a Supplement Facts panel reports elemental zinc, rather than the full weight of its zinc-containing compound. A paper reporting zinc sulphate and a label reporting zinc are therefore not necessarily describing the same quantity. A comparison needs the chemical form and the elemental amount; copying a number without its unit and formulation loses that distinction.

NIH also reports that high zinc intake can impair copper absorption. Its upper limits vary with age and are not eczema-treatment targets. Medical treatment is a separate circumstance requiring physician supervision. These facts do not supply a reason to add copper or zinc without assessment.

NIH Office of Dietary Supplements: labeling and excessive intake · Sources checked September 24, 2026.

What remains unanswered for an individual reader

The relevant evidence record needs the diagnosis, age group, measurement used to identify low zinc, background treatments and comparator. Then it needs an eczema outcome. A mineral result alone is not that outcome.

These oral studies do not test a topical zinc cream. They also do not establish a regimen for adults or a reason to discontinue prescribed eczema care. A clinician can assess whether a nutritional problem is present; the trial details here cannot diagnose one.

Oral placebo-controlled trial · Selected pediatric study · Sources checked September 24, 2026.

Reviewed September 24, 2026. Educational analysis; not individualized medical advice.

Ingredient evidence: vitamin D · fish oil · probiotics.